⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11844413 | 0.96 | LMNA (0.50) | — | |
| SCHEMBL12915594 | 0.85 | — | — | |
| SCHEMBL10391229 | 0.84 | — | — | |
| SCHEMBL7624733 | 0.84 | — | — | |
| SCHEMBL5699217 | 0.84 | — | — | |
| SCHEMBL10107553 | 0.84 | — | — | |
| SCHEMBL3620526 | 0.84 | — | — | |
| SCHEMBL991094 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL3509116 | 0.82 | LMNA (0.46) | — | |
| Hydrochloric Acid SCHEMBL4007391 | 0.82 | LMNA (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2668968-B1 | Polymeric ascorbic acid devices for tissue regeneration | COVIDIEN LP (US) | 2019-08-14 | — | — | EP | claimed |
| US-7527655-B1 | Reactive ink jet ink printing process | SAWGRASS TECHNOLOGIES, INC. (US) | 2009-05-05 | — | — | US | claimed |
| WO-2025100426-A1 | METHOD FOR DECOMPOSING CURED PRODUCT OF CURABLE RESIN COMPOSITION, METHOD FOR RECOVERING FILLER, AND METHOD FOR RECOVERING DECOMPOSED PRODUCT | 三菱瓦斯化学株式会社 | 2025-05-15 | — | — | WO | disclosed |
| WO-2025100425-A1 | AMINE-BASED CURING AGENT, CURABLE RESIN COMPOSITION, CURED PRODUCT, DECOMPOSITION METHOD FOR CURED PRODUCT, AND RECOVERY METHOD FOR FILLER | 三菱瓦斯化学株式会社 | 2025-05-15 | — | — | WO | disclosed |
| CN-113365984-B | LOX inhibitors | 癌症研究协会皇家癌症医院 | 2024-10-15 | — | — | CN | disclosed |
| EP-4406606-A2 | ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (APDCS) WITH ENZYMATICALLY CLEAVABLE G | Bayer Pharma Aktiengesellschaft (DE) | 2024-07-31 | — | — | EP | disclosed |
| EP-4328220-A1 | ADDITIVE FOR ELECTROLYTE, AND ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | Samsung SDI Co., Ltd. (KR) | 2024-02-28 | — | — | EP | disclosed |
| US-11806404-B2 | Site specific homogeneous with KSP inhibitors | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2023-11-07 | — | — | US | disclosed |
| EP-3898630-B1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2023-05-10 | — | — | EP | disclosed |
| US-20230017532-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2023-01-19 | — | — | US | disclosed |
| EP-3432934-B1 | PRODRUGS OF CYTOTOXIC AGENTS WITH ENZYMATICALLY CLEAVABLE GROUPS | Bayer Pharma AG (DE) | 2022-02-23 | — | — | EP | disclosed |
| US-5114961-A | 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists | MERCK & CO., INC. (US) | 1992-05-19 | — | — | US | disclosed |
| US-5011847-A | 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists | MERCK & CO., INC. (US) | 1991-04-30 | — | — | US | disclosed |
| US-5001123-A | 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists | MERCK & CO., INC. (US) | 1991-03-19 | — | — | US | disclosed |
| US-4996203-A | Platelet-activating factor antagonists | MERCK & CO., INC. (US) | 1991-02-26 | — | — | US | disclosed |
| EP-0402156-A1 | New 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists | MERCK & CO. INC. (US) | 1990-12-12 | — | — | EP | disclosed |
| EP-0402150-A1 | New 2,5-diaryl tetrahydrofurans and analogs therof as PAF antagonists | MERCK & CO. INC. (US) | 1990-12-12 | — | — | EP | disclosed |
| EP-0402155-A1 | New 2,5-diaryl tetrahydrofurans and analogs therof as PAF antagonists | MERCK & CO. INC. (US) | 1990-12-12 | — | — | EP | disclosed |
| EP-0402151-A1 | New 2, 5-diaryl tetrahydrofurans and analogs thereof as paf antagonists | MERCK & CO. INC. (US) | 1990-12-12 | — | — | EP | disclosed |
| US-3948901-A | Bis (2,4-dioxotetrahydropyrimidinyl-5-sulphonoamido) diphenylsulphoner | REZNIK VLADIMIR SAVICH | 1976-04-06 | — | — | US | disclosed |